Thomas McGarry

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

Michael H. Davidson, Thomas McGarry, Robert Bettis et al. · Journal of the American College of Cardiology · 2002 · 557 citations

Thrombosis, Primary Hypercholesterolemia, Lipid Disorder +7

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.

Gregg W. Stone, Stephen G. Ellis, Charles D O'Shaughnessy et al. · PubMed · 2006 · 272 citations

Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions

Mark Turco, John A. Ormiston, Jeffrey J. Popma et al. · Journal of the American College of Cardiology · 2007 · 102 citations

De Novo Lesions, Vascular Surgery, Lumen-apposing Metal Stent +3

The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty

Thomas McGarry, Ronald S. Gottlieb, Joel Morganroth et al. · American Heart Journal · 1992 · 92 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +10